Adverse events regardless of study drug relationship occurring in ≥5% of patients (grade 3/4) (N = 55)
| . | All grades, n (%) . | Grade 3, n (%) . | Grade 4, n (%) . |
|---|---|---|---|
| Nonhematologic | |||
| Diarrhea | 39 (70.9) | 10 (18.2) | 1 (1.8) |
| Fatigue | 38 (69.1) | 11 (20.0) | 0 |
| Nausea | 33 (60.0) | 3 (5.5) | 0 |
| Hypokalemia | 12 (21.8) | 2 (3.6) | 2 (3.6) |
| Hypotension | 11 (20.0) | 3 (5.5) | 2 (3.6) |
| Asthenia | 11 (20.0) | 5 (9.1) | 0 |
| Abdominal distention | 11 (20.0) | 4 (7.3) | 0 |
| Pneumonia | 9 (16.4) | 6 (10.9) | 2 (3.6) |
| Dehydration | 9 (16.4) | 2 (3.6) | 1 (1.8) |
| Abdominal pain | 9 (16.4) | 3 (5.5) | 0 |
| Flatulence | 6 (10.9) | 3 (5.5) | 0 |
| Sepsis | 5 (9.1) | 2 (3.6) | 3 (5.5) |
| Syncope | 5 (9.1) | 5 (9.1) | 0 |
| Septic shock | 3 (5.5) | 0 | 3 (5.5) |
| Hypophosphatemia | 3 (5.5) | 3 (5.5) | 0 |
| Hematologic | |||
| Thrombocytopenia | 36 (65.5) | 7 (12.7) | 28 (50.9) |
| Anemia | 26 (47.3) | 8 (14.5) | 0 |
| Neutropenia | 10 (18.2) | 5 (9.1) | 3 (5.5) |
| . | All grades, n (%) . | Grade 3, n (%) . | Grade 4, n (%) . |
|---|---|---|---|
| Nonhematologic | |||
| Diarrhea | 39 (70.9) | 10 (18.2) | 1 (1.8) |
| Fatigue | 38 (69.1) | 11 (20.0) | 0 |
| Nausea | 33 (60.0) | 3 (5.5) | 0 |
| Hypokalemia | 12 (21.8) | 2 (3.6) | 2 (3.6) |
| Hypotension | 11 (20.0) | 3 (5.5) | 2 (3.6) |
| Asthenia | 11 (20.0) | 5 (9.1) | 0 |
| Abdominal distention | 11 (20.0) | 4 (7.3) | 0 |
| Pneumonia | 9 (16.4) | 6 (10.9) | 2 (3.6) |
| Dehydration | 9 (16.4) | 2 (3.6) | 1 (1.8) |
| Abdominal pain | 9 (16.4) | 3 (5.5) | 0 |
| Flatulence | 6 (10.9) | 3 (5.5) | 0 |
| Sepsis | 5 (9.1) | 2 (3.6) | 3 (5.5) |
| Syncope | 5 (9.1) | 5 (9.1) | 0 |
| Septic shock | 3 (5.5) | 0 | 3 (5.5) |
| Hypophosphatemia | 3 (5.5) | 3 (5.5) | 0 |
| Hematologic | |||
| Thrombocytopenia | 36 (65.5) | 7 (12.7) | 28 (50.9) |
| Anemia | 26 (47.3) | 8 (14.5) | 0 |
| Neutropenia | 10 (18.2) | 5 (9.1) | 3 (5.5) |